Economic analysis of prophylactic granulocyte colony-stimulating factor (G-CSF) use based on a risk model for neutropenic complications in breast cancer patients receiving adjuvant chemotherapy.
Publication
, Conference
Dale, DC; Cosler, LE; Wolff, DA; Culakova, E; Poniewierski, MS; Crawford, J; Lyman, GH
Published in: JOURNAL OF CLINICAL ONCOLOGY
2006
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
Publication Date
2006
Volume
24
Issue
18
Start / End Page
327S / 327S
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Dale, D. C., Cosler, L. E., Wolff, D. A., Culakova, E., Poniewierski, M. S., Crawford, J., & Lyman, G. H. (2006). Economic analysis of prophylactic granulocyte colony-stimulating factor (G-CSF) use based on a risk model for neutropenic complications in breast cancer patients receiving adjuvant chemotherapy. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 24, pp. 327S-327S).
Dale, D. C., L. E. Cosler, D. A. Wolff, E. Culakova, M. S. Poniewierski, J. Crawford, and G. H. Lyman. “Economic analysis of prophylactic granulocyte colony-stimulating factor (G-CSF) use based on a risk model for neutropenic complications in breast cancer patients receiving adjuvant chemotherapy.” In JOURNAL OF CLINICAL ONCOLOGY, 24:327S-327S, 2006.
Dale DC, Cosler LE, Wolff DA, Culakova E, Poniewierski MS, Crawford J, et al. Economic analysis of prophylactic granulocyte colony-stimulating factor (G-CSF) use based on a risk model for neutropenic complications in breast cancer patients receiving adjuvant chemotherapy. In: JOURNAL OF CLINICAL ONCOLOGY. 2006. p. 327S-327S.
Dale, D. C., et al. “Economic analysis of prophylactic granulocyte colony-stimulating factor (G-CSF) use based on a risk model for neutropenic complications in breast cancer patients receiving adjuvant chemotherapy.” JOURNAL OF CLINICAL ONCOLOGY, vol. 24, no. 18, 2006, pp. 327S-327S.
Dale DC, Cosler LE, Wolff DA, Culakova E, Poniewierski MS, Crawford J, Lyman GH. Economic analysis of prophylactic granulocyte colony-stimulating factor (G-CSF) use based on a risk model for neutropenic complications in breast cancer patients receiving adjuvant chemotherapy. JOURNAL OF CLINICAL ONCOLOGY. 2006. p. 327S-327S.
Published In
JOURNAL OF CLINICAL ONCOLOGY
ISSN
0732-183X
Publication Date
2006
Volume
24
Issue
18
Start / End Page
327S / 327S
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences